Content about Medicinal chemistry

LEESBURG, Va. — A network of pharmacies formed with the goal of helping patients achieve better health outcomes while reducing costs has appointed a new executive to its leadership team.

RxAlly announced the appointment of Rebecca Chater as VP health outcomes. Chater, a pharmacist who has worked in clinical services for 20 years, will be responsible for providing leadership and clinical management of RxAlly solutions and integrating business development with clinical staff and operations.

A new report shows that drug makers lose nearly $200 billion per year from medication nonadherence, illustrating that it's not just the healthcare system overall that loses when people don't take their medications properly.

Ultimately, there’s no “retail pharmacy” without the “pharmacy,” and that’s true of any store that dispenses prescription drugs — whether it’s a small independent drug store, a nationwide chain, a supermarket or a mass merchandiser. But in many respects, Rite Aid is trying to make the “pharmacy” component of that phrase just a little bit bigger.


Some legislators are concerned with the way energy drinks can affect young consumers, especially in light of news reports linking several deaths with energy drink use.

Sens. Dick Durbin, D-Ill., and Richard Blumenthal, D-Conn., are urging the Food and Drug Administration to move quickly to review the safety of these drinks.

STAMFORD, Conn. — Drug maker Purdue Pharma and the National Community Pharmacists Association have introduced the latest version of a video designed to educate pharmacists and other pharmacy staff about pharmacy crime.

The video, part of RxPatrol, Purdue's broader initiative to combat pharmacy crime, launched on the initiative's website. Titled "RxPatrol Pharmacy Safety and Security," it is free of charge, and is part of the NCPA's Protect Your Pharmacy Now! initiative, which started in 2008.

NEW YORK — Americans woke up Wednesday morning to the news that Barack Obama had won a second term as president of the United States. Some people may be happy about that, others unhappy and others neutral — but win or lose, the results of Tuesday's election affect everyone, including those in the retail pharmacy industry.

WASHINGTON — Rx Response, an initiative of America’s bio-pharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, has continued its close coordination with federal, state and local government agencies to address impacts from Hurricane Sandy on the bio-pharmaceutical supply system, the organization announced Friday. 

CAMP HILL, Pa. – Rite Aid is stocking extra emergency supplies and keeping its pharmacies open as Hurricane Sandy bears down on the East Coast, the retail pharmacy chain said.

The company said that stores in the potential path of the storm had increased supplies of bottled water, flashlights, batteries, canned food for people and pets, first aid supplies, disposable cameras, duct tape and cleaning supplies.

SILVER SPRING, Md. — The Food and Drug Administration has given tentative approval to a new drug for HIV made by an Indian company.

FDA records show that the agency gave tentative approval tablets and oral suspension that combine lamivudine, nevirapine and zidovudine in the 30-mg/50-mg/60-mg strength.

Emerging multidisciplinary healthcare models, such as accountable care organizations and patient-centered medical homes, promise to elevate quality and lower costs by harnessing the power of provider, payer and patient collaboration. Often overlooked in the coordinated care equation, however, is the integral role pharmacists can play in delivering efficient and effective care.

Oh, Canada. In some ways, you’re showing your much bigger neighbor in the south the way forward in taking pharmacy to a higher level of practice. And if we’re smart, we’ll pay attention to the results. I’m talking about last week’s announcement by the provincial government of Ontario to expand the role of pharmacists so they can offer services that were previously the exclusive turf of the province’s 25,000 doctors.

SUMMIT, N.J. — The Food and Drug Administration has approved an injected drug for lung cancer made by Celgene, the company said Friday.

Celgene announced the approval of Abraxane (paclitaxel) protein-bound particles for injectable suspension, for the first-line treatment of non-small cell lung cancer that has advanced locally or spread to other parts of the body, in combination with carboplatin, for patients who are not candidates for curative surgery or radiation therapy.